Vanguard Personalized Indexing Management, LLC Pds Biotechnology Corp Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 28,523 shares of PDSB stock, worth $45,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,523Holding current value
$45,066% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.16MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$6.98 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$769,4070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$691,8510.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$406,3760.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $45M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...